# FDA recall D-0637-2024

> **Teva Pharmaceuticals USA, Inc** · Class II · drug recall initiated 2024-08-08.

## Product

Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA, Inc. North Wales, PA 19454, NDC 0591-2925-30. Packet NDC # 0591-2925-32 Carton NDC # 0591-2925-30

## Reason for recall

Superpotent Drug

## Distribution

Product was distributed nationwide within the United States

## Key facts

- **Recall number:** D-0637-2024
- **Recalling firm:** Teva Pharmaceuticals USA, Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-08-08
- **Report date:** 2024-08-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0637-2024

## Citation

> AI Analytics. FDA recall D-0637-2024. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0637-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*